ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite (HDM) Tablets in Allergic Rhinitis Environment Exposure Chamber Model

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01527188
Recruitment Status : Completed
First Posted : February 6, 2012
Last Update Posted : August 2, 2013
Sponsor:
Information provided by (Responsible Party):
Stallergenes Greer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : September 2012